In this briefing: VREOF: 4Q25 Earnings Preview LE: Snapping the Catalog: Ready for Spring with Swim, Prep, Linen; Reiterate Buy, PT Energy Transition: Brazil - Leapfrog to Electric Pakistan Automobiles: Car Sales Rose 42% YoY But Down 26% MoM To 17,121 Units In Feb 2026 Primer: Symphony Ltd (SYML IN) - Mar 2026 1. VREOF: 4Q25 Earnings Preview Key 4Q25 takeaways include: 1) management has remained aggressive on the M&A front, with recent agreements/MOUs to acquire Eaze, PharmaCann, Schwazze, and Hawthhorne 2) on a pro forma basis, Vireo Growth will operate 166 dispensaries across 10 states, with approximately 800,000 square feet of cultivation and production facilities 3) while we suspect senior officials will provide some color on deal-related accretion on the company's fourth quarter 2025 earnings conference call, our back-of the envelope math suggests a material step up in earnings power following the closings 4) the rescheduling of marijuana from Schedule I to Schedule III potentially paves the way for several key benefits for cannabis-related businesses including the deduction of business expenses on federal tax returns, improved access to banking/financial services, and less onerous tax burdens and 5) as uncertainty around rescheduling probabilities, implications, and timelines fade, we look for cannabis stocks to benefit from powerful upward revaluations. 2.